Table 2.
Outcome | Antenatal steroids | Indomethacin n/N (%) | Placebo n/N (%) | Odds ratio (95% CI)† | P value for interaction | ||
---|---|---|---|---|---|---|---|
Unadjusted | Adjusted for center/BW‡ | Adjusted for other factors§ | |||||
Death or impairment | Adequate | 145/319 (45.5) | 127/316 (40.2) | 1.24 (0.90, 1.70) | 0.13 | 0.10 | 0.15 |
Inadequate | 123/250 (49.2) | 133/251 (53.0) | 0.86 (0.61, 1.22) | ||||
Death | Adequate | 60/332 (18.1) | 45/331 (13.6) | 1.40 (0.92, 2.14) | 0.22 | 0.28 | 0.16 |
Inadequate | 64/258 (24.8) | 66/261 (25.3) | 0.97 (0.66, 1.45) | ||||
Cerebral palsy | Adequate | 37/270 (13.7) | 31/281 (11.0) | 1.28 (0.77, 2.13) | 0.23 | 0.23¶ | 0.27 |
Inadequate | 19/193 (9.8) | 24/194 (12.4) | 0.77 (0.41, 1.46) | ||||
Cognitive delay | Adequate | 68/257 (26.5) | 62/269 (23.0) | 1.20 (0.81, 1.78) | 0.34 | 0.25 | 0.26 |
Inadequate | 49/183 (26.8) | 54/186 (29.0) | 0.89 (0.57, 1.41) | ||||
Deafness | Adequate | 7/264 (2.7) | 5/276 (1.8) | 1.48 (0.46, 4.72) | 0.34 | 0.34¶ | 0.72 |
Inadequate | 3/188 (1.6) | 5/188 (2.7) | 0.59 (0.14, 2.52) | ||||
Blindness | Adequate | 4/268 (1.5) | 5/277 (1.8) | 0.82 (0.22, 3.11) | 0.30 | 0.29¶ | 0.53 |
Inadequate | 5/193 (2.6) | 2/193 (1.0) | 2.54 (0.49, 13.3) | ||||
Severe P/IVH | Adequate | 21/321 (6.5) | 28/322 (8.7) | 0.73 (0.41, 1.32) | 0.62 | 0.63 | 0.53 |
Inadequate | 31/245 (12.7) | 47/243 (19.3) | 0.60 (0.37, 0.99) | ||||
Patent ductus arteriosus (PDA) | Adequate | 72/335 (21.5) | 157/335 (46.9) | 0.31 (0.22, 0.43) | 0.89 | 0.99 | 0.78 |
Inadequate | 69/261 (26.4) | 144/264 (54.5) | 0.30 (0.21, 0.43) | ||||
Surgical closure of PDA | Adequate | 21/335 (6.3) | 40/335 (11.9) | 0.49 (0.28, 0.86) | 0.97 | 0.94¶ | 0.80 |
Inadequate | 18/261 (6.9) | 34/264 (12.9) | 0.50 (0.28, 0.91) |
CI, Confidence interval.
BW, Birth weight stratum.
In addition, adjusted for gestational age, gender, multiple births and mother’s education.
Adjusted for birth weight stratum only.